Prospective Randomized On-X Versus SJM Evaluation Trial (PROSE)
Thromboembolic Related Complications in a Randomized Trial of Previous and Current Generation Mechanical Valve Prostheses
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2000
- Royal Prince Alfred Hospital
-
-
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 1M9
- Vancouver General Hospital
-
Vancouver, British Columbia, Canada, V5Z 1M9
- St. Paul's Hospital
-
Victoria, British Columbia, Canada, V8R 4R2
- Victoria Heart Institute
-
-
New Brunswick
-
Saint John, New Brunswick, Canada, E2L 4L2
- Horizon New Brunswick Heart Centre
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1E2
- Jewish General Hospital
-
-
-
-
-
Freiburg, Germany, 79106
- Universitäts-Herzzentrum Bad Krozingen
-
Freiburg, Germany, 79106
- Universitats-Herzzentrum Freiburg - Medical Center
-
Jena, Germany, 7743
- Universitats Klinik Jena
-
Tübingen, Germany, 72074
- Universitat Klinik Tubingen
-
-
-
-
Gujarat
-
Sūrat, Gujarat, India, 395 001
- Sri Bachubahi Dayabhai Mehta Mahavir Heart Institute
-
-
Karnataka
-
Bangalore, Karnataka, India, 560 069
- Shri Jaya Deva Institute of Cardiovascular Sciences
-
-
Punjab
-
Ludhiāna, Punjab, India, 141 001
- Hero Dayanand Medical College and Hospitals
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India, 600 006
- Apollo Hospital Chennai
-
Chennai, Tamil Nadu, India, 600 101
- Frontier lifeline Hospital
-
Madurai, Tamil Nadu, India, 625 020
- Apollo Multispecialty Hospitals
-
-
Uttar Pradesh
-
Varanasi, Uttar Pradesh, India, 221 005
- Banaras Hindu University
-
-
-
-
-
Rotterdam, Netherlands, 3000 CA
- Erasmus Medical Center
-
-
-
-
-
Bergen, Norway, N-5021
- University of Bergen
-
-
-
-
-
Cape Town, South Africa, 7935
- Groote Schuur Hospital
-
-
-
-
-
Gothenburg, Sweden, SE41345
- Sahlgrenska University Hospital
-
-
-
-
California
-
Los Angeles, California, United States, 91101
- Southern California Permanente Medical Group
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96817
- Kaiser Foundation Hospital
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University - St Louis
-
Saint Louis, Missouri, United States, 63136
- Christian Hospital Northeast
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 08903
- Robert Wood Johnson Medical School
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
-
Virginia
-
Norfolk, Virginia, United States, 23507
- Sentara Norfolk General Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The patient requires an isolated mitral or isolated aortic valve replacement. (Patients undergoing coronary artery bypass and / or concomitant repair of mitral or tricuspid valves are eligible.)
- The patient is a candidate for receipt of a mechanical heart valve.
- The patient (or legal guardian) has signed a study-specific informed consent form agreeing to the randomization, data collection and follow-up requirements.
- The patient can be having a re-operative procedure, so long as the previous prosthetic valve is explanted and the patient does not become a double valve implantation patient.
Exclusion Criteria:
- The patient is not a candidate to receive a mechanical heart valve.
- The patient already has a prosthetic valve other than the valve(s) being replaced at this time.
- The patient requires a tricuspid valve replacement.
- The patient is enrolled in another investigative study or trial.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: ONX
On-X heart Valve Replacement
|
On-X Heart valve replacement
Other Names:
|
|
Active Comparator: SJM
SJM heart valve replacement
|
SJM Heart valve replacement
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thromboembolisms
Time Frame: 5 years
|
Frequency of occurrence for thromboembolic events, either major or reversible, as a function of valve type.
|
5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Eric Jamieson, MD, Vancouver Coastal Health Research Institute
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ONXSJM1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.